Table 2.
Multivariate Cox hazards models of survivals in all patients with non-small cell lung cancer.
| Overall survival |
Recurrence-free survival |
Cancer-specific survival |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Per unit for HR | HR | 95% CI | P – value | HR | 95% CI | P – value | HR | 95% CI | P – value |
| Age | 1-year | 1.034 | 1.015 − 1.052 | < 0.001 | 1.005 | 0.992 − 1.019 | 0.453 | 1.015 | 0.995 − 1.037 | 0.150 |
| Sex | Male/Female | 1.464 | 0.852 − 2.514 | 0.167 | 1.267 | 0.851 − 1.886 | 0.243 | 1.175 | 0.634 − 2.177 | 0.610 |
| Smoking status | Ever/Never and Unknown | 1.318 | 0.705 − 2.462 | 0.387 | 1.103 | 0.700 − 1.738 | 0.674 | 1.267 | 0.612 − 2.626 | 0.524 |
| Histology | SCC/ADC | 0.850 | 0.571 − 1.265 | 0.423 | 0.955 | 0.690 − 1.322 | 0.783 | 0.762 | 0.463 − 1.252 | 0.283 |
| Others/ADC | 1.564 | 0.941 − 2.599 | 0.085 | 1.249 | 0.802 − 1.947 | 0.326 | 1.332 | 0.712 − 2.494 | 0.370 | |
| Stage | 1-stage | 2.075 | 1.727 − 2.494 | < 0.001 | 2.356 | 2.024 − 2.741 | < 0.001 | 2.526 | 2.008 − 3.179 | < 0.001 |
| EGFR mutation with IHC | Positive/Negative | 0.929 | 0.574 − 1.502 | 0.762 | 0.912 | 0.634 − 1.312 | 0.618 | 0.904 | 0.497 − 1.643 | 0.740 |
| Tumoral CD200 expression | High/Low | 0.654 | 0.451 − 0.949 | 0.026 | 0.720 | 0.538 − 0.963 | 0.027 | 0.549 | 0.342 − 0.879 | 0.013 |
| Tumoral CD200R1 expression | High/Low | 1.308 | 0.923 − 1.855 | 0.132 | 0.958 | 0.733 − 1.251 | 0.751 | 1.688 | 1.073 − 2.654 | 0.024 |
| Stromal CD200R1 expression | High/Low | 1.259 | 0.901 − 1.759 | 0.177 | 1.114 | 0.840 − 1.477 | 0.454 | 1.070 | 0.701 − 1.632 | 0.755 |